NCT04840589
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04840589
Title Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
National Cancer Institute Developmental Therapeutics Clinic ACTIVE_NOT_RECRUITING Bethesda Maryland 20892 United States Details
National Institutes of Health Clinical Center ACTIVE_NOT_RECRUITING Bethesda Maryland 20892 United States Details
Mount Sinai Hospital ACTIVE_NOT_RECRUITING New York New York 10029 United States Details
Montefiore Medical Center-Einstein Campus RECRUITING The Bronx New York 10461 United States Details
Montefiore Medical Center-Weiler Hospital RECRUITING The Bronx New York 10461 United States Details
Montefiore Medical Center - Moses Campus RECRUITING The Bronx New York 10467 United States Details
Case Western Reserve University SUSPENDED Cleveland Ohio 44106 United States Details
Oregon Health and Science University RECRUITING Portland Oregon 97239 United States Details
University of Pittsburgh Cancer Institute (UPCI) RECRUITING Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field